Search details
1.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Article
in English
| MEDLINE | ID: mdl-34914339
2.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Lancet Oncol
; 24(3): 273-285, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36858723
3.
Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.
J Natl Compr Canc Netw
; 21(11): 1172-1180.e3, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37935109
4.
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
Biomarkers
; 28(3): 313-322, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36647745
5.
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
N Engl J Med
; 380(13): 1226-1234, 2019 03 28.
Article
in English
| MEDLINE | ID: mdl-30917258
6.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 380(25): 2395-2405, 2019 06 20.
Article
in English
| MEDLINE | ID: mdl-31157962
7.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 379(2): 111-121, 2018 Jul 12.
Article
in English
| MEDLINE | ID: mdl-29860917
8.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34120223
9.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Article
in English
| MEDLINE | ID: mdl-27406346
10.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Article
in English
| MEDLINE | ID: mdl-27406347
11.
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
Breast Cancer Res Treat
; 176(2): 303-310, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31004299
12.
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
Breast Cancer Res
; 20(1): 146, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30486865
13.
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.
Pharmacogenet Genomics
; 28(2): 49-55, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29278617
14.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
N Engl J Med
; 372(2): 134-41, 2015 Jan 08.
Article
in English
| MEDLINE | ID: mdl-25564897
15.
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
N Engl J Med
; 372(10): 923-32, 2015 03 05.
Article
in English
| MEDLINE | ID: mdl-25738668
16.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 373(21): 2005-14, 2015 Nov 19.
Article
in English
| MEDLINE | ID: mdl-26412349
17.
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 849-56, 2016 Feb 27.
Article
in English
| MEDLINE | ID: mdl-26686957
18.
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 857-65, 2016 Feb 27.
Article
in English
| MEDLINE | ID: mdl-26686960
19.
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
Br J Clin Pharmacol
; 81(6): 1134-41, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26859101
20.
Combination anastrozole and fulvestrant in metastatic breast cancer.
N Engl J Med
; 367(5): 435-44, 2012 Aug 02.
Article
in English
| MEDLINE | ID: mdl-22853014